Advertisement Amedica wins FDA clearance for SEEplate cervical plate system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Amedica wins FDA clearance for SEEplate cervical plate system

Amedica, an orthopedic and spinal implants company, has received the FDA 510(k) marketing clearance for the company's SEEplate cervical plate system.

The SEEplate cervical plate system incorporates features that are aimed at allowing surgeons an alternative to confirming the secure placement of the anti-back-out mechanism of screws used as part of the spinal implant system.

The SEEplate cervical plate system is intended for anterior screw fixation of cervical spine from the C2 through C7 vertebral bodies of the spine as an adjunct to cervical spine fusion.

Ashok Khandkar, CEO of Amedica, said: “FDA clearance of our SEEplate cervical plate system is another important milestone for Amedica. This cervical plate system will complement our line of innovative, silicon nitride ceramic spinal spacers, providing surgeons and patients with an important new option for spinal fixation.”